Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;84(1):69-77.
doi: 10.1016/j.pec.2010.07.005. Epub 2010 Aug 2.

Identifying patient information needs about cancer clinical trials using a Question Prompt List

Richard F Brown  1 , Elyse Shuk, Phyllis Butow, Shawna Edgerson, Martin H N Tattersall, Jamie S Ostroff
Affiliations

Identifying patient information needs about cancer clinical trials using a Question Prompt List

Richard F Brown et al. Patient Educ Couns. 2011 Jul.

Abstract

Objective: Question Prompt Lists (QPLs) have demonstrated significant promise in facilitating communication in general, surgical and palliative oncology settings yet have not been tested in the oncology clinical trial setting. We aimed to develop a targeted QPL for Clinical Trials (QPL-CT).

Methods: Breast, lung, and genitourinary cancer patients who either had (trial experienced) or had not (trial naive) participated in a clinical trial joined focus groups to help develop and explore the acceptability of a QPL-CT. Clinicians also participated in separated focus groups. Focus groups were audio-recorded and transcribed. We explored patients' trial information needs and views about the utility of the QPL-CT.

Results: Patients focused on four trial information needs: understanding foundational information, conflict of interest issues and financial implications of trial participation. Of note, experienced patients need to personalize foundational information.

Conclusion: Patient information needs varied considerably and were influenced by trial experience. Patients valued the QPL-CT as an aid to gathering new trial information and ensuring that their information needs were met.

Practice implications: Physicians need to carefully elicit patient information needs and tailor trial information to meet these needs. The QPL-CT, may be of great benefit during clinical trial discussions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Sampling Schema and Flowchart of Recruitment for Question Prompt List Focus Groups
See this image and copyright information in PMC

References

    1. Ellis P, Butow PN, Tattersall MHN, Dunn SM. Accrual to clinical trials in breast cancer. Annual Scientific Meeting of the Clinical Oncological Society of Australia; 1996; Brisbane, Australia. 1996.
    1. Avis NE, Smith KW, Link CI, Hortobagyi GN, Rivera N. Factors associated with participation in breast cancer clinical trials. Journal of Clinical Oncology. 2006;24(12):1860–7. - PubMed
    1. Lara PN, Higon N, Lim N, Kwa K, Tnaka M, Lau DH, et al. Prospective evaluation of clinical trial accrual patterns: identifying potential barriers to enrolment. Journal of Clinical Oncology. 2001;19:1728–33. - PubMed
    1. Hall A. In: The role of effective communication in obtaining informed consent in medical research. Loyal L, Tobias JS, editors. London: BMJ Books; 2001. pp. 290–8.
    1. Cox AC, Fallowfield LJ, Jenkins VA. Communication and the informed consent process in Phase I trials: a review of the literature. Support Care Cancer. 2006;14:303–9. - PubMed

Publication types